Introduction
BE Health and Taipei Medical University have co-launched the POC (proof of concept) Program that focuses on product or prototype-ready startups that are looking for traction in the Asian market. Based in Taipei, Taiwan, we leverage the unique strengths of our ecosystem to position our accelerator program as the gateway to Asia. Our unparalleled access to hospital facilities, research institutes, investors, healthcare experts, and other industry stakeholders help you secure funding and expand your market to Japan, Greater China, and SEA. Taipei Medical University has five world-class hospitals under their management, with a focus on innovation and smart hospitals, establishing themselves as the ideal Asian healthcare partner.
TMU BioMed Accelerator
Taiwan’s first international medical university accelerator with a perfect medical marketplace, clinical advantages, and experts in biomedical devices and artificial intelligence devoted to help startups fundraise, plan clinical trials, increase international relations, risk assessments, and enable medical pathways.
International Market Expansion Pilot Trial
Startups participating in the accelerator program could be selected for the opportunity to expand to US and Japan market through our international partners: UCSF Rosenman institute (US) and Premo (Japan). Selected startup teams would have opportunities to connect with key stakeholders and medical institutions in San Francisco and Tokyo.
Key
Acceleration
NEEDS VALIDATION
HOSPITAL PILOT SITE
CLINICAL IMMERSION
MEDICAL RESOURCE
R&D/ MANUFACTURING
INTELLECTUAL PROPERTY
LEGAL/ REGULATIONS
STAKEHOLDER ENGAGEMENT
REIMBURSEMENTS
FUNDRAISING
Startup Level
PoC proof of Concept startup focus
Purpose
Demo site at hospital
Funding
Opportunity to be funded
up to $200K market expansion
Roadshow
Local& International
(Japan, China, SEA, US) exposure
Duration
20-24 weeks
Medical Resources Support
Opportunity to get the TMU
trial program support
Taipei Medical University
-
Top academic and healthcare system in Taiwan
-
Vast clinical resources
-
Extensive experiences in collaborating with digital health and AI companies
Taipei Medical University Hospital
-
The world's first international safety hospital certification, 800 beds.
Wan Fang Hospital
-
The most complete international standardization, 743 beds.
Shuang Ho Hospital
-
The first BOT(Build-Operate-Transfer) hospital in the country, with a total of 1,600 beds.
Taipei Neuroscience Institute
-
The first international neuro medical center in Taiwan.
Hsin Kuo Min Hospital
-
Orthopedics Mainly, General Medicine.
Taipei Cancer Center
-
High-quality cancer center integrating cancer medical research, education, and clinical.
Focus Areas
Digital Health
-
Telehealth
-
Precision Medicine
-
Next Generation Sequencing
-
Smart Hospital
Artificial Intelligence
-
Medical Imaging
-
Auxiliary Diagnosis
-
Health Management
-
Drug Discovery
Medical Device
-
Advanced Biomaterials
-
Monitoring & Therapeutics
-
Delivery Platform
-
IVD diagnosis
Program Timeline
1
Validate
-
AI Medical Research Center
-
Need and product validation
-
Demo Site in Taiwan
2
Refine
-
Referring data scientist
-
Assisting data acquire
-
Preparing strategy to enter major Asian markets
-
Engaging stakeholders
-
Developing knowledge of the region
3
Implement
-
Achieving milestones
-
IP Strategy
-
Channel Strategy
-
Regulatory Strategy
-
Market Expansion
-
Investor Data Room
4
Next Stage Funding
-
Securing inward funding
-
Road Show
-
Opportunity to be funded up to 200K
